Abiopharma

News list

Director Silverman Joshua 🟢 acquired 100.0K shares of PharmaCyte Biotech, Inc. (PMCB) at $0.83 Transaction Date: Jan 05, 2026 | Filing ID: 000148

Full text

News bot Jan. 7, 2026, 10:45 p.m.
🔍 Silverman Joshua (Director)

Company: PharmaCyte Biotech, Inc. (PMCB)

Report Date: 2026-01-05
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 100,000
- Total shares held: 50,000
Detailed Transactions and Holdings:
- Acquired 30,000 shares of Common Stock at $0.7831 per share (Direct)
  Date: 2026-01-05 | Code: P | equity_swap_involved: 0 | shares_owned_after: 346,250.00 | transaction_form_type: 4
- Acquired 30,000 shares of Common Stock at $0.7889 per share (Direct)
  Date: 2026-01-06 | Code: P | equity_swap_involved: 0 | shares_owned_after: 376,250.00 | transaction_form_type: 4
- Acquired 40,000 shares of Common Stock at $0.8329 per share (Direct)
  Date: 2026-01-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 416,250.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-05 | Code: H | nature_of_ownership: JNS Holdings Group LLC | shares_owned_after: 50,000.00
Footnotes:
- REMARKS: Exhibit 24.1, Power of Attorney